nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A genomic enhancer signature associates with hepatocellular carcinoma prognosis
|
Jeon, Ah-Jung |
|
|
|
6 |
p. |
artikel |
2 |
A multicenter analysis of the role of prophylactic transfusion of blood products in patients with cirrhosis and esophageal varices undergoing endoscopic band ligation
|
Blasi, Annabel |
|
|
|
6 |
p. |
artikel |
3 |
An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma✰
|
Claasen, Marco P.A.W. |
|
|
|
6 |
p. |
artikel |
4 |
Approach to the patient with acute severe autoimmune hepatitis
|
Rahim, Mussarat N. |
|
|
|
6 |
p. |
artikel |
5 |
Assessing immunological and virological responses in the liver: Implications for the cure of chronic hepatitis B virus infection
|
Boettler, Tobias |
|
|
|
6 |
p. |
artikel |
6 |
Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma
|
Pinato, David J. |
|
|
|
6 |
p. |
artikel |
7 |
Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents
|
Chin, Justin |
|
|
|
6 |
p. |
artikel |
8 |
Association between statin exposure and short-term mortality in patients with high-grade acute-on-chronic liver failure
|
Chapin, Sara |
|
|
|
6 |
p. |
artikel |
9 |
A transcriptomic intratumour heterogeneity-free signature overcomes sampling bias in prognostic risk classification for hepatocellular carcinoma
|
Luo, Shangyi |
|
|
|
6 |
p. |
artikel |
10 |
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
|
Kerbert, Annarein J.C. |
|
|
|
6 |
p. |
artikel |
11 |
Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas
|
Hubers, Lowiek M. |
|
|
|
6 |
p. |
artikel |
12 |
Characterisation of hepatic lipid signature distributed across the liver zonation using mass spectrometry imaging
|
Seubnooch, Patcharamon |
|
|
|
6 |
p. |
artikel |
13 |
Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
|
Pflüger, Lisa Sophie |
|
|
|
6 |
p. |
artikel |
14 |
Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort
|
Hountondji, Lina |
|
|
|
6 |
p. |
artikel |
15 |
Contents
|
|
|
|
|
6 |
p. |
artikel |
16 |
Contents
|
|
|
|
|
6 |
p. iii |
artikel |
17 |
Contents
|
|
|
|
|
6 |
p. |
artikel |
18 |
Contents
|
|
|
|
|
6 |
p. |
artikel |
19 |
Contents
|
|
|
|
|
6 |
p. |
artikel |
20 |
Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease
|
Golabi, Pegah |
|
|
|
6 |
p. |
artikel |
21 |
Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p
|
Faure-Dupuy, Suzanne |
|
|
|
6 |
p. |
artikel |
22 |
Copyright and information
|
|
|
|
|
6 |
p. |
artikel |
23 |
Copyright and information
|
|
|
|
|
6 |
p. e1 |
artikel |
24 |
Copyright and information
|
|
|
|
|
6 |
p. |
artikel |
25 |
Copyright and information
|
|
|
|
|
6 |
p. |
artikel |
26 |
Copyright and information
|
|
|
|
|
6 |
p. |
artikel |
27 |
Deep learning model for prediction of hepatocellular carcinoma in patients with HBV-related cirrhosis on antiviral therapy
|
Nam, Joon Yeul |
|
|
|
6 |
p. |
artikel |
28 |
Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis
|
Tapper, Elliot B. |
|
|
|
6 |
p. |
artikel |
29 |
Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure
|
Goudsmit, Ben F.J. |
|
|
|
6 |
p. |
artikel |
30 |
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
|
Villeret, François |
|
|
|
6 |
p. |
artikel |
31 |
Early transplantation maximizes survival in severe acute-on-chronic liver failure: Results of a Markov decision process model
|
Zhang, Suyanpeng |
|
|
|
6 |
p. |
artikel |
32 |
Editorial Board
|
|
|
|
|
6 |
p. i |
artikel |
33 |
Editorial Board
|
|
|
|
|
6 |
p. |
artikel |
34 |
Editorial Board page
|
|
|
|
|
6 |
p. |
artikel |
35 |
Editorial Board page
|
|
|
|
|
6 |
p. |
artikel |
36 |
Editorial Board page
|
|
|
|
|
6 |
p. |
artikel |
37 |
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
|
Than, Nwe Ni |
|
|
|
6 |
p. 437-445 |
artikel |
38 |
Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results
|
van Baar, Annieke C.G. |
|
|
|
6 |
p. 429-437 |
artikel |
39 |
Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county
|
Suwabe, Tatsuya |
|
|
|
6 |
p. |
artikel |
40 |
Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg
|
Fernández-Barrena, Maite G. |
|
|
|
6 |
p. |
artikel |
41 |
Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis
|
Riva, Antonio |
|
|
|
6 |
p. |
artikel |
42 |
Fat, cancer, the gut-liver axis and rare liver diseases
|
Berenguer, Marina |
|
|
|
6 |
p. |
artikel |
43 |
Fulminant hepatitis A complicated by Takotsubo syndrome successfully treated with standard volume plasma exchange
|
Caballol, Berta |
|
|
|
6 |
p. 445-448 |
artikel |
44 |
Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma
|
Ricke, Jens |
|
|
|
6 |
p. |
artikel |
45 |
Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans
|
Heraghty, Neil |
|
|
|
6 |
p. |
artikel |
46 |
Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗MZ genotype
|
Chen, Vincent L. |
|
|
|
6 |
p. |
artikel |
47 |
Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor
|
Wang, Zhangting |
|
|
|
6 |
p. |
artikel |
48 |
Hepatic sarcoidosis: Clinical characteristics and outcome
|
Graf, Christiana |
|
|
|
6 |
p. |
artikel |
49 |
How to improve HCC surveillance outcomes
|
Sherman, Morris |
|
|
|
6 |
p. 460-467 |
artikel |
50 |
Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
|
Cannella, Roberto |
|
|
|
6 |
p. |
artikel |
51 |
Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease
|
Lim, Jihye |
|
|
|
6 |
p. |
artikel |
52 |
Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertension
|
Ortega-Ribera, Martí |
|
|
|
6 |
p. |
artikel |
53 |
Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
|
Hui, Vicki Wing-Ki |
|
|
|
6 |
p. |
artikel |
54 |
Influence of surgical approach and quality of resection on the probability of cure for early-stage HCC occurring in cirrhosis
|
Hobeika, Christian |
|
|
|
6 |
p. |
artikel |
55 |
Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
|
Wang, Huan |
|
|
|
6 |
p. |
artikel |
56 |
Intestinal Reg4 deficiency confers susceptibility to high-fat diet-induced liver steatosis by increasing intestinal fat absorption in mice
|
Wang, Ying |
|
|
|
6 |
p. |
artikel |
57 |
Lifestyle modification in NAFLD/NASH: Facts and figures
|
Hallsworth, Kate |
|
|
|
6 |
p. 468-479 |
artikel |
58 |
Lipid alterations in chronic liver disease and liver cancer
|
Paul, Bichitra |
|
|
|
6 |
p. |
artikel |
59 |
Liver toxicity as a limiting factor to the increasing use of immune checkpoint inhibitors
|
De Martin, Eleonora |
|
|
|
6 |
p. |
artikel |
60 |
Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
|
Nahon, Pierre |
|
|
|
6 |
p. 480-489 |
artikel |
61 |
Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
|
Graupera, Isabel |
|
|
|
6 |
p. |
artikel |
62 |
Monocyte dysfunction in decompensated cirrhosis is mediated by the prostaglandin E2-EP4 pathway
|
Maini, Alexander A. |
|
|
|
6 |
p. |
artikel |
63 |
NAFLD and liver transplantation: Disease burden, current management and future challenges
|
Burra, Patrizia |
|
|
|
6 |
p. |
artikel |
64 |
New targets for NAFLD
|
Parlati, Lucia |
|
|
|
6 |
p. |
artikel |
65 |
Non-invasive biomarkers of Fontan-associated liver disease
|
Emamaullee, Juliet |
|
|
|
6 |
p. |
artikel |
66 |
Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B
|
Moctezuma-Velázquez, Carlos |
|
|
|
6 |
p. |
artikel |
67 |
Pcsk9 knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice
|
Lebeau, Paul F. |
|
|
|
6 |
p. 418-429 |
artikel |
68 |
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
|
Innes, Hamish |
|
|
|
6 |
p. |
artikel |
69 |
PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation
|
Becattini, Barbara |
|
|
|
6 |
p. |
artikel |
70 |
Platelets in chronic liver disease, from bench to bedside
|
Ramadori, Pierluigi |
|
|
|
6 |
p. 448-459 |
artikel |
71 |
Pre-emptive TIPS for the treatment of bleeding from gastric fundal varices: Results of a randomised controlled trial
|
Escorsell, Angels |
|
|
|
6 |
p. |
artikel |
72 |
PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease
|
Nielsen, Mette J. |
|
|
|
6 |
p. |
artikel |
73 |
Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates
|
Garteiser, Philippe |
|
|
|
6 |
p. |
artikel |
74 |
Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities
|
Wang, Ping |
|
|
|
6 |
p. |
artikel |
75 |
Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review
|
Grønkjær, Lea Ladegaard |
|
|
|
6 |
p. |
artikel |
76 |
Reduced steatosis and weight as a result of specific diets or the dietitian themselves
|
Trivedi, Hirsh D. |
|
|
|
6 |
p. |
artikel |
77 |
Reply to: “Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans”
|
Ørntoft, Nikolaj W. |
|
|
|
6 |
p. |
artikel |
78 |
Reply to: “Reduced steatosis and weight as a result of specific diets or the dietitian themselves”
|
Holmer, Magnus |
|
|
|
6 |
p. |
artikel |
79 |
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
|
Garcia Garcia de Paredes, Ana |
|
|
|
6 |
p. |
artikel |
80 |
Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid
|
Hochberg, Jessica T. |
|
|
|
6 |
p. |
artikel |
81 |
Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors
|
Carrieri, Patrizia |
|
|
|
6 |
p. |
artikel |
82 |
Systemic iron reduction by venesection alters the gut microbiome in patients with haemochromatosis
|
Parmanand, Bhavika |
|
|
|
6 |
p. |
artikel |
83 |
The changing face of hepatology
|
Berenguer, Marina |
|
|
|
6 |
p. 415-417 |
artikel |
84 |
The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care
|
Hofmann, Wolf Peter |
|
|
|
6 |
p. |
artikel |
85 |
Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study
|
Ma, Haiyan |
|
|
|
6 |
p. |
artikel |
86 |
Time-resolved single-cell transcriptomics reveals the landscape and dynamics of hepatic cells in sepsis-induced acute liver dysfunction
|
Chen, Gan |
|
|
|
6 |
p. |
artikel |
87 |
Utility of novel viral and immune markers in predicting HBV treatment endpoints: A systematic review of treatment discontinuation studies
|
Zeng, Georgia |
|
|
|
6 |
p. |
artikel |
88 |
Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease
|
Guo, Yan |
|
|
|
6 |
p. |
artikel |